Pricing pressures on hip and knee implants in the US and Europe continue to drive manufacturers to find ways of diversifying their sales streams or distinguishing themselves from their competitors. Smith & Nephew PLC made the latest move with a $1.7 billion offer to acquire ArthroCare Corp.[See Deal]If completed, the purchase would expand Smith & Nephew’s sports medicine business while helping it diversify into the ear, nose, and throat market. The deal may not get done as analysts speculate that competitors Stryker Corp. and Johnson & Johnson could step in with counteroffers. But the interest surrounding Austin, TX-based ArthroCare emphasizes the pressures being put on large joint makers to find new ways of making money in orthopedics.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?